CAS No. 251106-10-2

Piperazine,1-(1H-benzimidazol-5-ylcarbonyl)-4-[(2,3-difluorophenyl)methyl]-

Piperazine,1-(1H-benzimidazol-5-ylcarbonyl)-4-[(2,3-difluorophenyl)methyl]-

Identification

Catalog number2020664
Chemical namePiperazine,1-(1H-benzimidazol-5-ylcarbonyl)-4-[(2,3-difluorophenyl)methyl]-
CAS RN 251106-10-2
Molecular formulaC19H18F2N4O

Structure

251106-10-2 structure

Classification

About Piperazine,1-(1H-benzimidazol-5-ylcarbonyl)-4-[(2,3-difluorophenyl)methyl]-

Piperazine,1-(1H-benzimidazol-5-ylcarbonyl)-4-[(2,3-difluorophenyl)methyl]- is a chemical compound registered under CAS number 251106-10-2, with the molecular formula C19H18F2N4O and a molecular weight of about 356.38 g/mol. CKSOne supplies Piperazine,1-(1H-benzimidazol-5-ylcarbonyl)-4-[(2,3-difluorophenyl)methyl]- for laboratory research and bulk production; product code 2020664. Send an inquiry for purity, packaging, price and lead time.

CAS Number
251106-10-2
Molecular Formula
C19H18F2N4O
Molecular Weight
356.38 g/mol
Related Keywords
piperazine
ylcarbonyl
benzimidazol
difluorophenyl
  • Copper;dichlorate;hexahydrate
  • Piperazine,1-([1,1'-biphenyl]-3-ylcarbonyl)-4-(6-ethylthieno[2,3-d]pyrimidin-4-yl)-,trifluoroacetate
  • Cycloheptanol, 4-methyl-, acetate, trans-
  • 1-(2-amino-6-bromo-phenyl)-2,2,2-trifluoro-ethanone
  • benzyl[2-[ethyl[3-methyl-4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]amino]ethyl]dimethylammonium acetate
  • Methyl 4,6-diaminonicotinate
    1379106-14-5
  • Phenol, 4-(3-amino-1H-pyrrolo[2,3-b]pyridin-5-yl)-
  • 2,4-Imidazolidinedione, 3-(2-methylphenyl)-1-[(4-nitrophenyl)methyl]-
  • 3,3'-[propane-2,2-diylbis(benzene-4,1-diyloxy)]bis(3-phenoxypropan-1-ol)
  • Benzenemethanol,a-cyclopropyl-4-[(1-methyl-1H-1,2,3-triazol-4-yl)sulfonyl]-
  • 4-Chlorobenzo[b]thiophene-2-carbonitrile
  • 6H-1,4-Dioxino[2,3-f]indole-7-carboxylic acid,6-ethyl-2,3-dihydro-8-(3,4,5-trimethoxyphenyl)-, methyl ester
    138044-02-7
  • Benzamide, 4,4'-(2,5-furandiyl)bis[N-[3-(dimethylamino)propyl]-
  • N-butyl-N-[3-(1,1-dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)propyl]-N-methylbutan-1-aminium
  • 1H-2,4-Benzodiazepine,3-[2-(2-furanyl)ethyl]-4,5-dihydro-4-methyl-1-phenyl-, (E)-2-butenedioate(1:1)
  • 2,2'-Bipyridine,4,4'-bis(7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-heptadecafluoro-5-tetradecenyl)-, (Z,Z)-
  • Benzene, [[(1E)-4-chloro-1-butenyl]thio]-
  • [1,1'-Biphenyl]-4-sulfonamide,N-[2,3,4,5-tetrahydro-3-oxo-2-(phenylmethyl)-1H-2-benzazepin-4-yl]-
    712274-83-4
  • Benzamide,2,4-dichloro-N-[2,2-dimethyl-1-[4-(propylsulfonyl)phenyl]propyl]-
  • Decanoic acid, 4-(octadecyloxy)-7-oxo-1,3,5-cycloheptatrien-1-yl ester
  • Butanoic acid, 1-methyl-3-phenyl-2-propynyl ester, (R)-
  • 1-(2-chloro-1,1-dioxido-1-benzothiophen-3-yl)-4-phenylpiperazine
  • Uridine, 3'-O-2-propynyl-, 2',5'-diacetate
  • 13500-66-8
  • ACETICACID,[[2,5-DIHYDRO-5-OXO-6-[2-[(TRIFLUOROACETYL)AMINO]PHENYL]-1,2,4-TRIAZIN-3-YL]THIO]-,ETHYLESTER
  • 1-(2-methoxyethyl)-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]piperidine
  • 3(2H)-Pyridazinone,6-[2-(1-hydroxycycloheptyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(1-methylethyl)-
  • 3-Morpholinone, 4-[4-(tetrahydro-2H-pyran-4-yl)phenyl]-
  • 1H-Indole-2-acetonitrile, a-ethylidene-, (Z)-
  • 2-Propenamide,3-(2-chlorophenyl)-N-[2,3,4,5-tetrahydro-2-(2-methylpropyl)-3-oxo-1H-2-benzazepin-4-yl]-, (2E)-
    712274-72-1
  • 3-Morpholinone, 4,5-dimethyl-6-phenyl-, trans-
  • L-Leucine, N-[N-[N-(1-carboxypentyl)-L-leucyl]-L-leucyl]-
  • 2,4,6-Cycloheptatrien-1-one,3-[[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]methyl]-2-hydroxy-6-(1-methylethyl)-
  • 1-[5-[5-[(3-quinolinylamino)methyl]-2-pyridinyl]-2-thienyl]Ethanone
  • 2H-1,4-Diazepin-2-one, hexahydro-4-[(4-nitrophenyl)methyl]-1-phenyl-
  • 2-Furancarboxylic acid, 5-butyl-2,3-dihydro-, ethyl ester, (2R)-
    389138-38-9